Aims: It was the aim of this study to measure spectral transmission of the human crystalline lens in situ. Method: The crystalline lens was illuminated by one of four light-emitting diodes of different colors. The relative spectral transmittance of the human crystalline lens was measured with the Purkinje-Sanson mirror images over a wide range of ages. Result: The study evaluated 36 crystalline lenses of 28 subjects aged 21–76 years. There was a significant correlation between the age and spectral transmittance for blue light. Conclusion: Spectral transmittance of the crystalline lens in situ could be measured with Purkinje-Sanson mirror images.

Keywords:
Blue light, Spectral transmittance, Cataract, Crystalline lens
1.
Koide R, Ueda TN, Dawson WW, Hope GM, Ellis A, Somuelson D, Ueda T, Iwabuchi S, Fukuda S, Matsuishi M, Yasuhara H, Ozawa T, Armstrong D: Retinal hazard from blue light emitting diode. J Jpn Ophthalmol Soc 2001;105:687–695.
2.
Cuthbertson FM, Peirson SN, Wulff K, Foster RG, Downes SM: Blue light-filtering intraocular lenses: review of potential benefits and side effect. J Cataract Refract Surg 2009;35:1281–1297.
3.
Kernt M, Neubauer AS, Liegl R, Eibl KH, Alge CS, Lackerbauer CA, Ulbig MW, Kampik A: Cytoprotective effects of a blue light-filtering intraocular lens on human retinal pigment epithelium by reducing phototoxic effects on vascular endothelial growth factor-alpha, Bax, and Bcl-2 expression. J Cataract Refract Surg 2009;35:354–362.
4.
Henderson BA, Grimes KJ: Blue-blocking IOLs: a complete review of the literature. Surv Ophthalmol 2010;55:284–289.
5.
Mainster MA, Turner PL: Blue-blocking IOLs decrease photoreception without providing significant photoprotection. Surv Ophthalmol 2010;55:272–289.
6.
Shiraya T, Kato S, Shigeeda T: Influence of a yellow-tinted intraocular lens on laser beam transmittance. Acta Ophthalmol 2011;89:37–39.
7.
Ao M, Chen X, Huang C, Li X, Hou Z, Chen X, Zhang C, Wang W: Color discrimination by patients with different types of light-filtering intraocular lenses. J Cataract Refract Surg 2010;36:389–395.
8.
Edwards KH, Gibson GA: Intraocular lens short wavelength light filtering. Clin Exp Optom 2010;93:390–399.
9.
Boettner EA, Wolter JR: Transmission of the ocular media. Invest Ophthalmol Vis Sci 1962;1:776–783.
10.
Lerman S, Borkman R: Spectroscopic evaluation and classification of the normal, aging, and cataractous lens. Ophthalmic Res 1976;8:335–353.
11.
Terada H, Sawa M, Akiba J, Ueno N, Chakrabarti B: Spectral transmittance of normal human crystalline lens. J Jpn Ophthalmol Soc 1994;98:1101–1108.
12.
Gaillard ER, Zheng L, Merriam JC, Dillon J: Age-related changes in the absorption characteristics of the primate lens. Invest Ophthalmol Vis Sci 2000;41:1454–1459.
13.
Ranjan M, Beedu SR: Spectroscopic and biochemical correlations during the course of human lens aging. BMC Ophthalmol 2006;6:10.
14.
Kessel L, Lundeman JH, Herbst K, Andersen TV, Larsen: Age-related changes in the transmission properties of the human lens and their relevance to circadian entrainment. J Cataract Refract Surg 2010;36:308–312.
15.
Said FS, Weale RA: The variation with age of the spectral transmissivity of the living human crystalline lens. Gerontologia 1959;3:213–231.
16.
Emery JM, Little JH: Phacoemulsification, and Aspiration of Cataracts; Surgical Techniques, Complications, and Results. St. Louis, Mosby, 1979, pp 45–48.
17.
Guidelines on limits of exposure to broad-band incoherent optical radiation (0.38 to 3 µm). Health Physics 1997;73:539–554.
18.
Bron AJ, Vrensen GF, Koretz J, Maraini G, Harding JJ: The ageing lens. Ophthalmologica 2000;214:86–104.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.